Estimates Revisions Henan Lingrui Pharmaceutical Co., Ltd.
Stocks
600285
CNE000001501
Pharmaceuticals
|
End-of-day quote
Shanghai S.E.
2026-08-13
|
5-day change | 1st Jan Change | ||
| 19.67 CNY | -3.91% |
|
-11.36% | -5.02% |
| 08-11 | Lingrui Pharmaceutical H1 Profit Up 4.4%; Shares Fall 9% | MT |
| 08-11 | Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- 600285 Stock
- Consensus Henan Lingrui Pharmaceutical Co., Ltd.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
